publication . Article . Other literature type . 2017

Attitudes of oncology healthcare practitioners towards smoking cessation: A systematic review of the facilitators, barriers and recommendations for delivery of advice and support to cancer patients

Conlon, K.; Pattinson, L.; Hutton, D.;
Open Access
  • Published: 01 Aug 2017 Journal: Radiography, volume 23, pages 256-263 (issn: 1078-8174, Copyright policy)
  • Publisher: Elsevier BV
  • Country: United Kingdom
Abstract Objectives A systematic review of the literature was conducted. The review was conducted using a search of the literature for all years up to October 2016. Statements that identified facilitators, barriers or recommendations surrounding smoking cessation delivery were extracted and analogous statements aggregated to enable thematic analysis. After searching multiple databases and the application of exclusion and inclusion criteria, a total of 19 acceptable studies were identified. Key findings Delivery of cessation by oncology professionals was impacted by their own knowledge and views, their perception of the benefits to patient health and by the workp...
free text keywords: Radiology Nuclear Medicine and imaging, Oncology, medicine.medical_specialty, medicine, Nursing, Smoking cessation, medicine.medical_treatment, Family medicine, business.industry, business, Smoking cessation advice, Internal medicine, Thematic analysis, Cancer, medicine.disease, Health care
17 references, page 1 of 2

1. World Health Organization. WHO global report on trends in tobacco smoking 2000-2025. Available from: [Accessed: 4th November 2016].

2. World Health Organization. WHO report on the global tobacco epidemic, 2015. Available from: [Accessed 4th November 2016].

3. Callum C, Boyle S, Sandford A, Christen WG, Law MR, Hackshaw AK, et al. Estimating the cost of smoking to the NHS in England and the impact of declining prevalence. Heal Econ Policy Law 2011;6:489-508. doi:10.1017/S1744133110000241.

4. Public Health England. Making Every Contact Count (MECC): Consensus statement 2016. 2016. Available from: [Accessed 1st November 2016]

5. National Institute of Health and Care Excellence. Smoking: brief interventions and referrals. PH1. London: NICE; 2006.

6. Public Health England. Health matters: smoking and quitting in England. 2015. Available from: [Accessed 4th November 2016].

7. Public Health England. Smokefree mental health services in England: Implementation document for providers of mental health services. 2016. Available from: _England__Guidance_for_Providers.pdf [Accessed 7th November 2016].

8. National Institute of Health and Care Excellence. Smoking: stopping in pregnancy and after childbirth. PH26. London: NICE; 2010.

9. Duffy SA, Ronis DL, Valenstein M, Fowler KE, Lambert MT, Bishop C, et al. Depressive Symptoms, Smoking, Drinking, and Quality of Life Among Head and Neck Cancer Patients. Psychosomatics 2007;48:142-8. doi:10.1176/appi.psy.48.2.142.

10. Blanchard CM, Courneya KS, Stein K, American Cancer Society's SCS-II. Cancer survivors' adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society's SCS-II. J Clin Oncol 2008;26:2198-204. doi:10.1200/JCO.2007.14.6217.

11. Peppone LJ, Mustian KM, Morrow GR, Dozier AM, Ossip DJ, Janelsins MC, et al. The effect of cigarette smoking on cancer treatment-related side effects. Oncologist 2011;16:1784-92. doi:10.1634/theoncologist.2011-0169. [OpenAIRE]

12. Duffy SA, Ronis DL, McLean S, Fowler KE, Gruber SB, Wolf GT, et al. Pretreatment health behaviors predict survival among patients with head and neck squamous cell carcinoma. J Clin Oncol 2009;27:1969- 75. doi:10.1200/JCO.2008.18.2188.

13. Parsons A, Daley A, Begh R, Aveyard P. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ 2010;340:b5569- b5569. doi:10.1136/bmj.b5569. [OpenAIRE]

14. Maxwell JH, Kumar B, Feng FY, Worden FP, Lee JS, Eisbruch A, et al. Tobacco Use in Human Papillomavirus-Positive Advanced Oropharynx Cancer Patients Related to Increased Risk of Distant Metastases and Tumor Recurrence. Clin Cancer Res 2010;16.

15. Khuri FR, Lee JJ, Lippman SM, Kim ES, Cooper JS, Benner SE, et al. Randomized phase III trial of lowdose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients. J Natl Cancer Inst 2006;98:441-50. doi:10.1093/jnci/djj091.

17 references, page 1 of 2
Powered by OpenAIRE Research Graph
Any information missing or wrong?Report an Issue